Status:
UNKNOWN
Effect of Iron Deficiency Anemia on HBA1C in Patients With Diabetic Foot Ulcer Grade (1and2)
Lead Sponsor:
Assiut University
Conditions:
Iron Deficiency Anemia
HBA1C
Eligibility:
All Genders
18+ years
Brief Summary
Diabetic foot ulcer is the commonest cause of severe limb ischemia in diabetes mellitus And development of anemia is an additional burden to the microvascular complications of diabetes
Detailed Description
HBA1C is the predominant Hemoglobin found in HBA1 fraction and it constitutes 5% of total Hemoglobin in normal adults and up to 15%in patients with diabetes mellitus HBA1C is used to diagnose diabetes...
Eligibility Criteria
Inclusion
- all diabetic patients with diabetic foot ulcer grade one and two above 18 year
Exclusion
- patients with anemia other than iron deficiency anemia
- Patients on anticoagulants
- patients with blood disease 4-patients below 18
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04131608
Start Date
February 1 2021
End Date
December 1 2021
Last Update
January 13 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.